Skip to main content
SpringerLink
Log in

Adalimumab/infliximab

Various toxicities: 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Desbois AC, et al. Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients. Clinical Immunology 197: 54-59, Dec 2018. Available from: URL: http://doi.org/10.1016/j.clim.2018.08.004 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/infliximab. Reactions Weekly 1724, 17 (2018). https://doi.org/10.1007/s40278-018-52996-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-52996-5

Search

Navigation